Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$2.09 - $4.32 $250 - $518
120 Added 1.16%
10,492 $24,000
Q3 2022

Nov 03, 2022

BUY
$2.24 - $4.18 $201 - $376
90 Added 0.88%
10,372 $28,000
Q2 2022

Aug 02, 2022

SELL
$2.85 - $7.77 $2,972 - $8,104
-1,043 Reduced 9.21%
10,282 $29,000
Q1 2022

May 09, 2022

SELL
$5.7 - $9.3 $1,425 - $2,325
-250 Reduced 2.16%
11,325 $86,000
Q4 2021

Jan 26, 2022

SELL
$8.73 - $15.27 $37,381 - $65,386
-4,282 Reduced 27.0%
11,575 $101,000
Q3 2021

Nov 05, 2021

SELL
$13.52 - $23.95 $48,077 - $85,166
-3,556 Reduced 18.32%
15,857 $220,000
Q2 2021

Aug 13, 2021

SELL
$22.12 - $32.06 $25,216 - $36,548
-1,140 Reduced 5.55%
19,413 $469,000
Q1 2021

May 10, 2021

BUY
$26.12 - $52.17 $33,511 - $66,934
1,283 Added 6.66%
20,553 $658,000
Q4 2020

Feb 05, 2021

BUY
$14.05 - $29.0 $36,206 - $74,733
2,577 Added 15.44%
19,270 $475,000
Q3 2020

Nov 09, 2020

BUY
$14.17 - $19.48 $26,724 - $36,739
1,886 Added 12.74%
16,693 $239,000
Q2 2020

Jul 31, 2020

BUY
$13.25 - $21.72 $13,568 - $22,241
1,024 Added 7.43%
14,807 $239,000
Q1 2020

Apr 24, 2020

SELL
$9.73 - $24.9 $603 - $1,543
-62 Reduced 0.45%
13,783 $198,000
Q4 2019

Feb 07, 2020

BUY
$14.22 - $23.38 $24,671 - $40,564
1,735 Added 14.33%
13,845 $292,000
Q3 2019

Nov 06, 2019

BUY
$22.93 - $41.06 $29,809 - $53,378
1,300 Added 12.03%
12,110 $278,000
Q2 2019

Aug 06, 2019

BUY
$38.73 - $52.03 $69,016 - $92,717
1,782 Added 19.74%
10,810 $436,000
Q1 2019

May 15, 2019

BUY
$28.11 - $50.77 $37,723 - $68,133
1,342 Added 17.46%
9,028 $392,000
Q4 2018

Feb 08, 2019

BUY
$26.22 - $56.89 $48,533 - $105,303
1,851 Added 31.72%
7,686 $206,000
Q3 2018

Nov 06, 2018

BUY
$24.31 - $52.74 $141,848 - $307,737
5,835 New
5,835 $283,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $3.05B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.